• PanFab
  • NEJM
  • #COVIDLawBriefing
  • Outspoken Oncology Podcast
  • Generic But Expensive
  • Antitrust and Pharmaceuticals
  • HMS Gender Equity in Global Surgery
  • The U.S. Opioid Epidemic: Where Do We Go From Here?
  • Tax Cuts and Jobs act
  • The Ethics of Health Care Reform

Dr. Sinha is a Research Fellow at the Harvard-MIT Center for Regulatory Science, within the Harvard Program in Therapeutic Science (HiTS) at Harvard Medical School. He is also affiliated with the Program On Regulation, Therapeutics, And Law (PORTAL), within the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine at Brigham and Women’s Hospital and the Center for Health Policy and Law at Northeastern University School of Law. Medical publications have appeared in NEJM, JAMA, JAMA Internal Medicine, Mayo Clinic Proceedings, CHEST, PLOS Medicine, Health Affairs, the American Journal of Public Health, and the American Journal of Bioethics. His legal scholarship includes articles in the Journal of Legal Medicine, the American Journal of Law & Medicine, the American Journal of Law and Medicine, the Journal of Law, Medicine & Ethics, the Harvard Law & Policy Review, the Food and Drug Law Journal, the Stanford Law & Policy Review, the Journal of Law and the Biosciences, and the Hastings Law Journal.